Wellnex Life Limited reported unaudited revenue results for the first half of fiscal year of 2022. Revenue for the first half of FY22 was up18.5% up on the prior corresponding period (PCP) to $8.84 million (unaudited), with an additional $1.6 million in Purchase Orders received to be invoiced in the second half of 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 AUD | +12.50% |
|
+8.00% | +17.39% |
05/06 | Wellnex Life to Launch Medicinal Cannabis Product Range; Shares Fall 3% | MT |
24/05 | Wellnex Life Partners Chemist Warehouse to Reintroduce Pain Away in New Zealand | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.39% | 2.06Cr | |
+30.94% | 3.02TCr | |
-16.69% | 412.63Cr | |
+7.48% | 389.87Cr | |
-8.48% | 171.15Cr | |
-2.61% | 161.4Cr | |
-14.45% | 124.2Cr | |
-22.59% | 105.38Cr | |
-36.61% | 80Cr | |
+2.77% | 65Cr |
- Stock Market
- Equities
- WNX Stock
- News Wellnex Life Limited
- Wellnex Life Limited Reports Unaudited Revenue Results for the First Half of Fiscal Year of 2022